Self Injection Device Market Drivers and Opportunities [2021-2031]
The Self Injection Device Market is expected to register a CAGR of 11.50% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report presents an analysis based on by product dosage form (single dose, multi-dose). The report further provides analysis based on type (needle free, auto, pen, wearable injectors). The global analysis is further broken-down at regional level and major countries. The market size and forecast at global, regional, and country levels for all the key market segments are covered under the scope. The report offers the value in USD for the above analysis and segments. The report provides key statistics on the market status of the key market players and offers market trends and opportunities.
Purpose of the ReportThe report Self Injection Device Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Self Injection Device Market Segmentation
Dosage form- Single Dose
- Multi-Dose
- Needle Free
- Auto
- Pen
- Wearable Injectors
Strategic Insights
Self Injection Device Market Growth Drivers- Increasing Numbers of Chronic Illnesses: Increasing incidences of chronic diseases like diabetes and rheumatoid arthritis is an important reason driving the self-injection device market expansion. Such patients usually opt for regular medication causing increased demand in self-administration devices providing for users' complete convenience, compliance to therapy and adds growth opportunities for market expansion.
- Increase in Home Health Care: This shift is basing on the demand from patients for autonomy and convenience in their management of the treatment process. According to this trend, with self-injection devices, patients can take treatment therapy at home instead of having to visit a hospital facility. Encouraging innovation on the part of manufacturers to develop a patient-friendly user device meant for home use.
- Evolution in Technologies Related to Device Designs: The advancements such as auto-injectors and needle-free systems in technologies on self-injection devices have increasingly changed usability and experience of the patient. These high-performance inventions facilitate easing use, safety during treatment, and comforts that will spark increased adoption among patients and healthcare providers, hence driving the growth of the market.
- Exploiting Biologic Medications: Demand for self-injection devices is mounting because of the increased adoption of biologic medicines for chronic conditions. Biologics are usually dosed accurately and injected frequently, so device manufacturers are currently working on the advancement of delivery systems promising accurate and safe self-injection for patients.
- Customization and Personalization of Devices: The trend is gearing towards an increasing amount of customization in self-injection devices, which is focused on the personalized needs of patients. Flexibility is being sought, so that the patient may either personalize or select features according to the user-preferable conditions or preferences for maximizing satisfaction and compliance.
- Advanced Safety Features: Manufacturers are now focusing on building self-injection devices with better safety mechanisms, such as automatic needle recluse and safety locks. These benefits will reduce the possibility of unintentionally pricking needles and improve the overall safety of the system, thereby taking care of the concerns raised by patients and health care professionals.
- Emerging Market Expansion: The emerging markets are today offering unlimited opportunities for manufacturers as health care is improving in such areas. Within affordable and self-injection devices customized locally, the thousands of people yearning to procure solutions for chronic disease management are more readily accessed.
- Collaboration with Pharmaceutical Companies: Partnership with pharmaceutical companies may improve product development in self-injection devices. A collaboration may open up a co-brand within which medicine is delivered through particular delivery systems as part of the product to potentially improve patient outcomes and create a better market access for both companies.
- Research and Development Investment:Investment in research and development with a focus on promoting innovative delivery mechanisms provides an opportunity for manufacturers. Next-generation self-injection devices could be developed, incorporating advanced technologies that would offer differentiation of products in a highly competitive market while meeting evolving patient needs.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Self Injection Device Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Self Injection Device Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORKHave a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Becton Dickinson and Company, West Pharmaceutical Services, Gerresheimer AG, Insulet Corporation, Ypsomed AG, Antares Pharma, Inc. are some of the major players operating in the market.
The single dose segment accounts for the highest revenue by dosage form in 2023.
Asia Pacific region dominated the self injection device market in 2023.
North America region dominated the self injection device market in 2023.
The Self Injection Device Market is estimated to witness a CAGR of 11.50% from 2023 to 2031
The major factors driving the self injection device market are:
1. Increasing Numbers of Chronic Illnesses
2. Increase in Home Health Care
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Self Injection Device Market - By Dosage form
1.3.2 Self Injection Device Market - By Type
1.3.3 Self Injection Device Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SELF INJECTION DEVICE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SELF INJECTION DEVICE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SELF INJECTION DEVICE MARKET - GLOBAL MARKET ANALYSIS
6.1. SELF INJECTION DEVICE - GLOBAL MARKET OVERVIEW
6.2. SELF INJECTION DEVICE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. SELF INJECTION DEVICE MARKET - REVENUE AND FORECASTS TO 2028 - DOSAGE FORM
7.1. OVERVIEW
7.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
7.3. SINGLE DOSE
7.3.1. Overview
7.3.2. Single Dose Market Forecast and Analysis
7.4. MULTI-DOSE
7.4.1. Overview
7.4.2. Multi-Dose Market Forecast and Analysis
8. SELF INJECTION DEVICE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. NEEDLE FREE
8.3.1. Overview
8.3.2. Needle Free Market Forecast and Analysis
8.4. AUTO
8.4.1. Overview
8.4.2. Auto Market Forecast and Analysis
8.5. PEN
8.5.1. Overview
8.5.2. Pen Market Forecast and Analysis
8.6. WEARABLE INJECTORS
8.6.1. Overview
8.6.2. Wearable Injectors Market Forecast and Analysis
9. SELF INJECTION DEVICE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Self Injection Device Market Overview
9.1.2 North America Self Injection Device Market Forecasts and Analysis
9.1.3 North America Self Injection Device Market Forecasts and Analysis - By Dosage form
9.1.4 North America Self Injection Device Market Forecasts and Analysis - By Type
9.1.5 North America Self Injection Device Market Forecasts and Analysis - By Countries
9.1.5.1 United States Self Injection Device Market
9.1.5.1.1 United States Self Injection Device Market by Dosage form
9.1.5.1.2 United States Self Injection Device Market by Type
9.1.5.2 Canada Self Injection Device Market
9.1.5.2.1 Canada Self Injection Device Market by Dosage form
9.1.5.2.2 Canada Self Injection Device Market by Type
9.1.5.3 Mexico Self Injection Device Market
9.1.5.3.1 Mexico Self Injection Device Market by Dosage form
9.1.5.3.2 Mexico Self Injection Device Market by Type
9.2. EUROPE
9.2.1 Europe Self Injection Device Market Overview
9.2.2 Europe Self Injection Device Market Forecasts and Analysis
9.2.3 Europe Self Injection Device Market Forecasts and Analysis - By Dosage form
9.2.4 Europe Self Injection Device Market Forecasts and Analysis - By Type
9.2.5 Europe Self Injection Device Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Self Injection Device Market
9.2.5.1.1 Germany Self Injection Device Market by Dosage form
9.2.5.1.2 Germany Self Injection Device Market by Type
9.2.5.2 France Self Injection Device Market
9.2.5.2.1 France Self Injection Device Market by Dosage form
9.2.5.2.2 France Self Injection Device Market by Type
9.2.5.3 Italy Self Injection Device Market
9.2.5.3.1 Italy Self Injection Device Market by Dosage form
9.2.5.3.2 Italy Self Injection Device Market by Type
9.2.5.4 Spain Self Injection Device Market
9.2.5.4.1 Spain Self Injection Device Market by Dosage form
9.2.5.4.2 Spain Self Injection Device Market by Type
9.2.5.5 United Kingdom Self Injection Device Market
9.2.5.5.1 United Kingdom Self Injection Device Market by Dosage form
9.2.5.5.2 United Kingdom Self Injection Device Market by Type
9.2.5.6 Rest of Europe Self Injection Device Market
9.2.5.6.1 Rest of Europe Self Injection Device Market by Dosage form
9.2.5.6.2 Rest of Europe Self Injection Device Market by Type
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Self Injection Device Market Overview
9.3.2 Asia-Pacific Self Injection Device Market Forecasts and Analysis
9.3.3 Asia-Pacific Self Injection Device Market Forecasts and Analysis - By Dosage form
9.3.4 Asia-Pacific Self Injection Device Market Forecasts and Analysis - By Type
9.3.5 Asia-Pacific Self Injection Device Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Self Injection Device Market
9.3.5.1.1 Australia Self Injection Device Market by Dosage form
9.3.5.1.2 Australia Self Injection Device Market by Type
9.3.5.2 China Self Injection Device Market
9.3.5.2.1 China Self Injection Device Market by Dosage form
9.3.5.2.2 China Self Injection Device Market by Type
9.3.5.3 India Self Injection Device Market
9.3.5.3.1 India Self Injection Device Market by Dosage form
9.3.5.3.2 India Self Injection Device Market by Type
9.3.5.4 Japan Self Injection Device Market
9.3.5.4.1 Japan Self Injection Device Market by Dosage form
9.3.5.4.2 Japan Self Injection Device Market by Type
9.3.5.5 South Korea Self Injection Device Market
9.3.5.5.1 South Korea Self Injection Device Market by Dosage form
9.3.5.5.2 South Korea Self Injection Device Market by Type
9.3.5.6 Rest of Asia-Pacific Self Injection Device Market
9.3.5.6.1 Rest of Asia-Pacific Self Injection Device Market by Dosage form
9.3.5.6.2 Rest of Asia-Pacific Self Injection Device Market by Type
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Self Injection Device Market Overview
9.4.2 Middle East and Africa Self Injection Device Market Forecasts and Analysis
9.4.3 Middle East and Africa Self Injection Device Market Forecasts and Analysis - By Dosage form
9.4.4 Middle East and Africa Self Injection Device Market Forecasts and Analysis - By Type
9.4.5 Middle East and Africa Self Injection Device Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Self Injection Device Market
9.4.5.1.1 South Africa Self Injection Device Market by Dosage form
9.4.5.1.2 South Africa Self Injection Device Market by Type
9.4.5.2 Saudi Arabia Self Injection Device Market
9.4.5.2.1 Saudi Arabia Self Injection Device Market by Dosage form
9.4.5.2.2 Saudi Arabia Self Injection Device Market by Type
9.4.5.3 U.A.E Self Injection Device Market
9.4.5.3.1 U.A.E Self Injection Device Market by Dosage form
9.4.5.3.2 U.A.E Self Injection Device Market by Type
9.4.5.4 Rest of Middle East and Africa Self Injection Device Market
9.4.5.4.1 Rest of Middle East and Africa Self Injection Device Market by Dosage form
9.4.5.4.2 Rest of Middle East and Africa Self Injection Device Market by Type
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Self Injection Device Market Overview
9.5.2 South and Central America Self Injection Device Market Forecasts and Analysis
9.5.3 South and Central America Self Injection Device Market Forecasts and Analysis - By Dosage form
9.5.4 South and Central America Self Injection Device Market Forecasts and Analysis - By Type
9.5.5 South and Central America Self Injection Device Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Self Injection Device Market
9.5.5.1.1 Brazil Self Injection Device Market by Dosage form
9.5.5.1.2 Brazil Self Injection Device Market by Type
9.5.5.2 Argentina Self Injection Device Market
9.5.5.2.1 Argentina Self Injection Device Market by Dosage form
9.5.5.2.2 Argentina Self Injection Device Market by Type
9.5.5.3 Rest of South and Central America Self Injection Device Market
9.5.5.3.1 Rest of South and Central America Self Injection Device Market by Dosage form
9.5.5.3.2 Rest of South and Central America Self Injection Device Market by Type
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. SELF INJECTION DEVICE MARKET, KEY COMPANY PROFILES
11.1. BECTON
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. DICKINSON AND COMPANY
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. WEST PHARMACEUTICAL SERVICES
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GERRESHEIMER AG
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. INSULET CORPORATION
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. YPSOMED AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ANTARES PHARMA, INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. CONSORT MEDICAL PLC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SENSILE MEDICAL AG.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1.Becton
2.Dickinson and Company
3.West Pharmaceutical Services
4.Gerresheimer AG
5.Insulet Corporation
6.Ypsomed AG
7.Antares Pharma, Inc.
8.Consort Medical plc.
9.Sensile Medical AG.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.